New perspectives in advanced genitourinary malignancies

被引：0
|
作者：
Biondani, Pamela [1 ]
Procopio, Giuseppe [1 ]
Pietrantonio, Filippo [1 ]
de Braud, Filippo [1 ]
Verzoni, Elena [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumor, Med Oncol Unit 1, I-20133 Milan, Italy
来源：
TUMORI JOURNAL | 2012年 / 98卷 / 02期
关键词：
genitourinary malignancies; renal cell cancer; bladder cancer; prostate cancer; targeted therapies; RENAL-CELL CARCINOMA; INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB;
D O I：
10.1177/030089161209800215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The management of advanced genitourinary malignancies has undergone a major transformation with the advent of novel drugs and targeted therapies in recent years. Assessment of the treatment risks and benefits is required for each patient and therefore better knowledge of the different clinical and molecular aspects of these diseases is warranted. The results of further studies and biomarker validations are expected to provide more treatment options and improve outcomes in the future management of genitourinary malignancies.
引用
收藏
页码：267 / 269
页数：3
相关论文
共 50 条
  • [1] Preface to "Management of advanced genitourinary malignancies"
    Todenhoefer, Tilman
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 3915 - 3917
  • [2] UNDERUTILIZATION OF PALLIATIVE SERVICES IN ADVANCED GENITOURINARY MALIGNANCIES
    Bernstein, Adrien
    Golan, Ron
    Dinerman, Brian
    Fainberg, Jonathan
    Al Awamlh, Bashir Al Hussein
    Hu, Jim C.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E930 - E930
  • [3] Telemedicine in management of genitourinary malignancies: Patient and physician perspectives
    Margolin, Ezra J.
    Martina, Luis A. Pina
    Miles, Caleb H.
    Wenske, Sven
    McKiernan, James M.
    DeCastro, G. Joel
    Hyams, Elias S.
    Drake, Charles G.
    Lim, Emerson A.
    Stein, Mark N.
    Deutsch, Israel
    Anderson, Christopher B.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (08) : 480 - 486
  • [4] GENITOURINARY MALIGNANCIES
    SELMAN, SH
    [J]. PRIMARY CARE, 1989, 16 (04): : 1013 - 1030
  • [5] Cost Considerations for Systemic Therapy for Patients With Advanced Genitourinary Malignancies
    Henry, Mark A.
    Leung, Andrew
    Filson, Christopher P.
    [J]. CANCER, 2018, 124 (14) : 2897 - 2905
  • [6] Re: Cost Considerations for Systemic Therapy for Patients with Advanced Genitourinary Malignancies
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (01): : 184 - 185
  • [7] The Role of PD-L1 Testing in Advanced Genitourinary Malignancies
    Hahn, Andrew W.
    Sirohi, Deepika
    Agarwal, Neeraj
    [J]. EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 11 - 13
  • [8] Immunotherapy of Genitourinary Malignancies
    Inamoto, Teruo
    Azuma, Haruhito
    [J]. JOURNAL OF ONCOLOGY, 2012, 2012
  • [9] Immunotherapy in genitourinary malignancies
    Wattenberg, Max M.
    Fong, Lawrence
    Madan, Ravi A.
    Gulley, James L.
    [J]. CURRENT OPINION IN UROLOGY, 2016, 26 (06) : 501 - 507
  • [10] Cabozantinib in genitourinary malignancies
    Zhang, Tian
    Park, Se Eun
    Hong, Cierra
    George, Daniel J.
    [J]. FUTURE ONCOLOGY, 2017, 13 (08) : 755 - 765
12345